A systematic review of the health economic consequences of quadrivalent influenza vaccination-Reference-Cited by-同舟云学术

A systematic review of the health economic consequences of quadrivalent influenza vaccination

Published:2017-05-04 Issue:3 Volume:17 Page:249-265
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

de Boer Pieter T.¹,van Maanen Britt M.¹,Damm Oliver²,Ultsch Bernhard³,Dolk Franklin C.K.¹,Crépey Pascal⁴⁵,Pitman Richard⁶,Wilschut Jan C.⁷,Postma Maarten J.¹⁸⁹^ORCID

Affiliation:

1. Unit of PharmacoTherapy, -Epidemiology & -Economics (PTE2), Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands

2. Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, Germany

3. Immunisation Unit, Robert Koch Institute, Berlin, Germany

4. Department of Quantitative Methods in Public Health, EHESP Rennes, Sorbonne Paris Cité, Rennes, France

5. UPRES-EA-7449 Reperes, University of Rennes 1, Rennes, France

6. ICON Health Economics and Epidemiology, Oxford, UK

7. Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

8. Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

9. Institute of Science in Healthy Aging & healthcaRE (SHARE), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2017.1343145

Reference72 articles.

1. World Health Organization. Influenza (seasonal) [Internet]. 2014. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.

2. The annual impact of seasonal influenza in the US: Measuring disease burden and costs

3. The rationale for quadrivalent influenza vaccines

4. Caini S, Huang QS, Ciblak MA, et al. Epidemiological and virological characteristics of influenza B: results of the global influenza B study. Influenza Other Respir Viruses. 2015;9:3–12.

5. Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Adjuvanted Quadrivalent Influenza Vaccine in Older-Age Adults: A Systematic Review of Economic Evidence;Vaccines;2024-05-10

2. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives;BMC Public Health;2024-05-03

3. Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022;PLOS Medicine;2024-01-05

4. Efficacy and safety of pediatric flu vaccination: a systematic review;Revista Española de Quimioterapia;2023-12-05

5. Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews;BMC Infectious Diseases;2023-08-29